ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 366 out of 1185

$341K Total Retail Price of All Prescriptions

Rank: 453 out of 1185

417 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 417 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 417 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,547 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
WARFARIN SODIUM 274 256 1 21
PRAVASTATIN SODIUM 254 191 2 7
ZOLPIDEM TARTRATE 241 179 3 15
HYDROCODONE-ACETAMINOPHEN 237 167 S3 4 2
TRAMADOL HCL 220 193 5 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 214 164 6 14
AMLODIPINE BESYLATE 197 172 7 1
PREDNISONE 182 151 8 33
OMEPRAZOLE 178 154 9 6
LEVOTHYROXINE SODIUM 170 143 10 3
METFORMIN HCL 158 116 11 9
POTASSIUM CHLORIDE 135 117 12 18
GABAPENTIN 125 99 13 13
METOPROLOL TARTRATE 120 108 14 10
LISINOPRIL 117 102 15 4
HYDROCHLOROTHIAZIDE 114 96 16 12
FLUTICASONE PROPIONATE 102 68 17 29
AZITHROMYCIN 102 80 17 39
FUROSEMIDE 99 86 19 8
GLIPIZIDE 91 73 20 56
CITALOPRAM HBR 90 71 21 22
RANITIDINE HCL 90 48 21 17
MELOXICAM 88 59 23 27
ALLOPURINOL 75 73 24 30
LOSARTAN-HYDROCHLOROTHIAZIDE 74 71 25 36
TAMSULOSIN HCL 73 51 26 34
SIMVASTATIN 71 60 27 5
ATENOLOL 68 61 28 28
NEXIUM 67 33 29 19
CYCLOBENZAPRINE HCL 66 49 R 30 53
FLUOXETINE HCL 60 45 31 52
METOPROLOL SUCCINATE 59 51 32 20
BUSPIRONE HCL 56 35 33 148
DIGOXIN 55 54 34 67
PAROXETINE HCL 50 39 35 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.